Analystreport

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com